Department of Neurology, Medical University of Warsaw, Warsaw, Poland.
Neurodegenerative Diseases Research Group, Medical University of Warsaw, Warsaw, Poland.
Amyotroph Lateral Scler Frontotemporal Degener. 2021 Feb;22(1-2):80-85. doi: 10.1080/21678421.2020.1803359. Epub 2020 Aug 10.
Mutations in cause approximately 12-25% of familial ALS and ≈2% of apparently sporadic ALS cases. Clinical phenotypes linked to SOD1 mutations are heterogeneous and intra-familial variability of the clinical phenotype is frequently observed. SOD1 L144S mutation, identified also in Brazil, Iran and United States, is the second most frequent mutation among ALS patients in Poland. So far, 10 FALS pedigrees with SOD1 L144S mutation have been reported worldwide. The aim of the study was to establish the origin of SOD1 L144S mutation in geographically distinct populations. The clinical presentation of the Polish patients was compared with those from the previously reported populations (26 ever-reported patients). Clinically, L144S mutation is associated with both sporadic and familial ALS of relatively slow uniform course, a prevalent onset in the lower limbs, either classic or PMA presentation and a long survival time. Like in the case of other previously described SOD1 mutations, there was an intra-familial heterogeneity and reduced penetrance for ALS was observed. We propose that the L144S SOD1 mutation in the three studied populations has a common founder most likely of Polish origin.
导致约 12-25%的家族性 ALS 和 ≈2%的明显散发性 ALS 病例的突变。与 SOD1 突变相关的临床表型是异质的,并且经常观察到家族内临床表型的变异性。SOD1 L144S 突变也存在于巴西、伊朗和美国,是波兰 ALS 患者中第二常见的突变。迄今为止,全世界已经报道了 10 个具有 SOD1 L144S 突变的 FALS 家系。本研究的目的是确定 SOD1 L144S 突变在地理上不同人群中的起源。将波兰患者的临床表现与先前报道的人群(26 名曾报道的患者)进行比较。临床上,L144S 突变与相对缓慢均匀进展的散发性和家族性 ALS 相关,下肢首发,经典或 PMA 表现,生存时间长。与其他先前描述的 SOD1 突变一样,观察到家族内异质性和 ALS 的低外显率。我们提出,在三个研究人群中,L144S SOD1 突变具有共同的起源,最有可能来自波兰。